跳至主要内容
临床试验/IRCT20130903014551N4
IRCT20130903014551N4已完成3 期

The effect of curcumin supplementation on cardiovascular risk factors and kidney function on patients with stage 3 and 4 of chronic kidney disease (CKD)

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • The patient's tendency to participate in study and signing approval form
  • no use of non steroidal anti-inflammatory drugs, Nicotinic Acid, estrogen, progesterone and Curcumin supplementation for at least one month before the start of the study
  • Lack of drug addiction
  • Lack of severe heart disease, liver failure and thyroid diseases, severe gastrointestinal bleeding and peptic ulcer disease, cholelithiasis, pregnancy or lactation
  • Age between 18-75 years old
  • Stage 3:GFR:15-29
  • Stage 4:GFR:30-59

排除标准

  • kidney transplantation
  • The use of herbal medicines as lipid lowering agents
  • Receive omega-3 fatty acids and carnitine at least 1 month before the start of the study

研究者

相似试验